SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 12 of 100
Newsletters
How chief health officers could help campuses navigate COVID
By
Sy Mukherjee
Conferences
These cofounders believe sewage is the key to tracking COVID
By
Sy Mukherjee
Health
The myth—and danger—of COVID herd immunity
By
Sy Mukherjee
Newsletters
Last night’s debate ignored some critical health care issues
By
Sy Mukherjee
Health
COVID treatments like the experimental antibody therapeutic Trump received are making progress
By
Sy Mukherjee
Health
Trump wants a COVID vaccine before Election Day, but fewer Americans are saying they’ll get one
By
Sy Mukherjee
Health
How President Trump got special access to his coronavirus treatment
By
Sy Mukherjee
Health
Trump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted
By
Sy Mukherjee
Newsletters
Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By
Sy Mukherjee
Politics
Trump’s 4 biggest lies about health care from last night’s debate
By
Sy Mukherjee
Conferences
How 3 of biopharma’s most powerful women are building public trust during COVID
By
Sy Mukherjee
Health
The world is obsessed with new COVID drugs. But other important treatments are in the works, too
By
Sy Mukherjee
Newsletters
COVID and the flu present a clash of viruses
By
Sy Mukherjee
Health
Where the 4 major coronavirus vaccine candidates currently stand
By
Sy Mukherjee
Newsletters
Eli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results
By
Sy Mukherjee